Stacey Ruiz, PhD

VP, Drug Development and Medical Affairs

Dr. Ruiz has led drug development for a variety of indications, including chronic kidney disease, cardiovascular disease, and autoimmune disease. She has managed pharmacology, toxicology, and clinical programs for small molecules, peptides, and biologics. Her broad expertise extends to strategic guidance on product messaging, company operations, business development, and regulatory filings.

Prior to joining Renibus Therapeutics, Dr. Ruiz was VP of Drug Development and Discovery at Abcentra. She was previously Director of Research and Development and Business Development at La Jolla Pharmaceutical Company and held leadership roles in Product Development and Medical Affairs at Reata Pharmaceuticals.

Dr. Ruiz completed her postdoctoral training at Harvard Medical School/Dana-Farber Cancer Institute after earning her PhD in Cancer Biology from The University of Texas Health Science Center/MD Anderson Cancer Center. She received her undergraduate degree from the University of Notre Dame.

Back to Home